✦ LIBER ✦

Involved field radiation therapy following high dose chemotherapy and autologous stem cell transplant benefits local control and survival in refractory or recurrent Hodgkin lymphoma

✍ Scribed by Tithi Biswas; Eva Culakova; Jonathan W. Friedberg; Jennifer L. Kelly; Sughosh Dhakal; Jane Liesveld; Gordon L. Phillips; Louis S. Constine

Book ID: 116855668
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 316 KB
Volume: 103
Category: Article
ISSN: 0167-8140
DOI: 10.1016/j.radonc.2011.12.031

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High-dose chemotherapy and autologous st

High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma

✍ Park, Kwonoh; Yoon, Dok Hyun; Kim, Shin; Park, Chan-Sik; Huh, Jooryung; Lee, San 📂 Article 📅 2013 🏛 Carden Jennings Publishing 🌐 English ⚖ 191 KB

High-dose chemotherapy and autologous st

High-dose chemotherapy and autologous stem cell transplant in adolescent patients with relapsed or refractory Hodgkin's lymphoma

✍ El Weshi, A; Rahal, M; Abdelsalam, M; Al Husseini, H; Maghfoor, I; Akhtar, S 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 200 KB

Prognostic factors for disease progressi

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma

✍ Popat, U; Hosing, C; Saliba, R M; Anderlini, P; Besien, K van; Przepiorka, D; Kh 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 167 KB

Consolidative involved field radiotherap

Consolidative involved field radiotherapy after high dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma: a case-control study

✍ Christoph Oehler-Jänne; Christian Taverna; Nadine Stanek; Laura Negretti; Urs M. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

## Abstract The role of involved field radiation therapy (IF‐RT) after high dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) for non‐Hodgkin's lymphoma (NHL) has not been conclusively defined. It has been hypothesized that HDC might obviate the need of consolidative IF‐RT. A

BEAC or BEAM high-dose chemotherapy foll

BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin’s lymphoma patients: comparative analysis of efficacy and toxicity

✍ Jae-Cheol Jo; Byung Wook Kang; Geundoo Jang; Sun Jin Sym; Sung Sook Lee; Ja Eun 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 144 KB

High-dose carmustine, etoposide, and cis

High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory lymphoma: An effective regimen with low morbidity and mortality

✍ Punit D. Wadhwa; Pingfu Fu; Omer N. Koc; Brenda W. Cooper; Robert M. Fox; Richar 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 276 KB